CA2286335A1 - Procedes d'obtention d'antigenes specifiques aux champignons, anticorps pour ces antigenes et diagnostic de maladie au moyen de ces antigenes et/ou anticorps - Google Patents

Procedes d'obtention d'antigenes specifiques aux champignons, anticorps pour ces antigenes et diagnostic de maladie au moyen de ces antigenes et/ou anticorps Download PDF

Info

Publication number
CA2286335A1
CA2286335A1 CA002286335A CA2286335A CA2286335A1 CA 2286335 A1 CA2286335 A1 CA 2286335A1 CA 002286335 A CA002286335 A CA 002286335A CA 2286335 A CA2286335 A CA 2286335A CA 2286335 A1 CA2286335 A1 CA 2286335A1
Authority
CA
Canada
Prior art keywords
antigens
antibodies
methods
fungi
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002286335A
Other languages
English (en)
Other versions
CA2286335C (fr
Inventor
Gary J. Weil
Ramaswamy Chandrashekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barnes Hospital
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2286335A1 publication Critical patent/CA2286335A1/fr
Application granted granted Critical
Publication of CA2286335C publication Critical patent/CA2286335C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA002286335A 1997-04-15 1998-04-15 Procedes d'obtention d'antigenes specifiques aux champignons, anticorps pour ces antigenes et diagnostic de maladie au moyen de ces antigenes et/ou anticorps Expired - Fee Related CA2286335C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4333297P 1997-04-15 1997-04-15
US60/043,332 1997-04-15
PCT/US1998/007728 WO1998046738A1 (fr) 1997-04-15 1998-04-15 Procedes d'obtention d'antigenes specifiques aux champignons, anticorps pour ces antigenes et diagnostic de maladie au moyen de ces antigenes et/ou anticorps

Publications (2)

Publication Number Publication Date
CA2286335A1 true CA2286335A1 (fr) 1998-10-22
CA2286335C CA2286335C (fr) 2007-02-27

Family

ID=21926632

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286335A Expired - Fee Related CA2286335C (fr) 1997-04-15 1998-04-15 Procedes d'obtention d'antigenes specifiques aux champignons, anticorps pour ces antigenes et diagnostic de maladie au moyen de ces antigenes et/ou anticorps

Country Status (3)

Country Link
AU (1) AU7128098A (fr)
CA (1) CA2286335C (fr)
WO (1) WO1998046738A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003506099A (ja) * 1999-08-05 2003-02-18 オイ メディックス バイオケミカ エービー 選択された指標真菌の抗原性成分およびその抗原性成分の方法と試験キットでの使用
ATE414172T1 (de) 1999-08-06 2008-11-15 Oragenics Inc Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden
US7033748B2 (en) 1999-08-06 2006-04-25 Ivigene Corporation Identification of microbial polynucleotides expressed during infection of a host
US7052837B2 (en) 2001-03-13 2006-05-30 The Board Of Trustees Of The University Of Arkansas Histoplasma capsulatum catalase sequences and their use in the detection of Histoplamsa capsulatum and histoplasmosis
US7217519B1 (en) 2002-11-21 2007-05-15 The Board Of Trustees Of The University Of Arkansas Histoplasma capsulatum chitin synthase sequences and their use for detection of Histoplasma capsulatum and histoplasmosis

Also Published As

Publication number Publication date
CA2286335C (fr) 2007-02-27
WO1998046738A1 (fr) 1998-10-22
AU7128098A (en) 1998-11-11

Similar Documents

Publication Publication Date Title
EP0914344B8 (fr) ANALYSES ET REACTIFS PERMETTANT DE QUANTIFIER LE hBNP
EP0852004A2 (fr) Analyse multiplexee de specimens cliniques
CA2198958A1 (fr) Methode d'amplification du signal de reponse dans un immunodosage de type sandwich
CA2250141A1 (fr) Anticorps monoclonaux de l'antigene membranaire specifique de la prostate
AU1674400A (en) Kidney disease detection and treatment
AU572125B2 (en) Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
AU3260299A (en) Immunoassays involving surface enhanced raman scattering
Berman et al. Amplification of the biotin-avidin immunofluorescence technique
DK0564494T3 (da) Testmetode og reagenssæt dertil
EP0974671A8 (fr) Procede permettant de diagnostiquer un dysfonctionnement du metabolisme osseux
AU1245188A (en) Analyte detection in particulate-containing samples
CA2286335A1 (fr) Procedes d'obtention d'antigenes specifiques aux champignons, anticorps pour ces antigenes et diagnostic de maladie au moyen de ces antigenes et/ou anticorps
EP0869177A3 (fr) Récepteurs humains du facteur de croissance dérivé des plaquettes du type A et B
BR0016458A (pt) Reagentes, métodos e kits para detectar proteìnas de bacillus thuringiensis
CA2294514A1 (fr) Procede d'identification d'antigenes de proteines cellulaires et de detection de la presence d'anticorps diriges contre des proteines cellulaires specifiques du serum
WO2001075449A1 (fr) Technique d'investigation du cancer par epreuve biologique d'un autoanticorps contre mdm2 et reactif
EP0331514A3 (fr) Essai de la délétion ou du défaut de la protéine de la dystrophie musculaire de Duchenne
CA2346406A1 (fr) Detection de pleiotrophine
WO1998029726A3 (fr) Procede de detection de la troponine i et de determination de sa concentration totale dans un echantillon biologique
AU6688700A (en) Diagnostic assay for human matrix gla-protein and its use as a biomarker
CA2213083A1 (fr) Detection de la production d'anticorps
DE69924617D1 (de) Immunologische Bestimmung des hydrophoben Lungensurfaktantproteins SP-C
WO1998022825A3 (fr) Procede et trousse de dosage du sang entier et du facteur mitogene servant a effectuer la detection precoce du cancer chez un sujet
SE9501782D0 (sv) Method of predicting the therapeutic response of a drug against a malignant tumour

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130415